ask="3.23"
ask_size="200"
average_daily_volume="1010600"
bid="2.79"
bid_size="200"
book_value="0.32"
change="+0.07"
change_from_200_day_moving_average="0.84"
change_from_50_day_moving_average="0.43"
change_from_52_week_high="-0.03"
change_From_52_week_low="2.15"
change_in_percent="+2.55%"
close="2.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.16"
ebitda="-24.62M"
eps_estimate_current_year="-0.09"
eps_estimate_next_quarter="-0.02"
eps_estimate_next_year="0.09"
ex_dividend_date="N/A"
float_shares="116713000"
high="2.85"
high_52_weeks="2.85"
last_trade_date="3/16/2017"
last_trade_price="2.82"
last_trade_size="15884"
last_trade_time="4:00pm"
low="2.72"
low_52_weeks="0.67"
market_capitalization="437.34M"
moving_average_200_day="1.98"
moving_average_50_day="2.39"
name="Antares Pharma
Inc."
notes="N/A"
one_year_target_price="4.00"
open="2.78"
pe_ratio="N/A"
peg_ratio="-0.39"
percent_change_from_200_day_moving_average="+42.19%"
percent_change_from_50_day_moving_average="+17.99%"
percent_change_from_52_week_high="-1.05%"
percent_change_from_52_week_low="+320.90%"
previous_close="2.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="31.33"
price_per_book="8.70"
price_per_sales="8.56"
revenue="49.83M"
shares_outstanding="155086000"
short_ratio="2.32"
stock_exchange="NCM"
symbol="ATRS"
volume="1586256"
weeks_range_52="0.67 - 2.85"
